Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V., a foreign private issuer, covers the month of November 2022. The report, dated November 9, 2022, serves primarily to incorporate by reference unaudited condensed consolidated financial statements and management discussion for the three and nine months ended September 30, 2022, into the company's registration statements on Form S-8 and Form F-3.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are located in the incorporated exhibits (Exhibit 99.1 and 99.2) rather than the cover document text. Consequently, no clear financial values can be extracted from this specific input.
Material Changes
The filing text does not provide specific details regarding material changes in financial performance or operations compared to prior periods. Such analysis is contained within the Management's Discussion and Analysis (Exhibit 99.2) referenced in this report.
Guidance, Outlook, and Risks
This document does not include management commentary, forward-looking guidance, or specific risk factors. It references a press release dated November 9, 2022 (Exhibit 99.4), but explicitly states that this exhibit is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into the registration statements.
Investor Verification Checklist
- Review Exhibit 99.1 for the actual unaudited condensed consolidated financial statements for the periods ended September 30, 2022.
- Examine Exhibit 99.2 for Management's Discussion and Analysis to understand operational results and financial condition.
- Consult the press release (Exhibit 99.4) for any recent corporate announcements, noting it is not legally "filed" under the Exchange Act.
- Verify the incorporation by reference status of these exhibits into the active Form S-8 and Form F-3 registration statements.